Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Glycemic control was slightly better with lixisenatide: mean postbaseline difference, -0.27% (95% CI: -0.32 to -0.22)
10.1136/bmj.d4169 183
Understanding the mechanisms behind this muscle loss, the factors that influence it, and evidence-based strategies to preserve muscle function helps patients and clinicians optimize treatment outcomes while maintaining strength and functional independence throughout therapy
Anchorage & Wasilla (907) 929-4825 Phoenix (602) 851-7853
US$ 28.54
US$ 22.08
US$ 21.51
